National Multiple Sclerosis Society

OrganisationROR

Trials

  • NCT03896217

    Collaborator, Phase 2, Completed, 40 people, 29 Mar 2019

  • NCT03500289

    Collaborator, Phase 1/2, Completed, 18 people, 18 Apr 2018

  • NCT03166800

    Collaborator, Phase 1/2, Terminated, 9 people, 25 May 2017

  • NCT03051646

    Collaborator, Early phase 1, Completed, 12 people, 14 Feb 2017

  • NCT02133664

    Collaborator, Phase 1/2, Completed, 54 people, 8 May 2014

  • NCT01451593

    Collaborator, Phase 2, Completed, 92 people, 13 Oct 2011

  • NCT00682929

    Collaborator, Phase 1/2, Terminated, 41 people, 23 May 2008

  • NCT00467584

    Collaborator, Phase 3, Terminated, 62 people, 30 Apr 2007

  • NCT00405353

    Collaborator, Phase 1/2, Completed, 10 people, 30 Nov 2006

Funded papers

Sources: api.crossref.org, pubmed.ncbi.nlm.nih.gov

Named in competing interests

Sources: pubmed.ncbi.nlm.nih.gov